JP2016010330A5 - - Google Patents

Download PDF

Info

Publication number
JP2016010330A5
JP2016010330A5 JP2014132622A JP2014132622A JP2016010330A5 JP 2016010330 A5 JP2016010330 A5 JP 2016010330A5 JP 2014132622 A JP2014132622 A JP 2014132622A JP 2014132622 A JP2014132622 A JP 2014132622A JP 2016010330 A5 JP2016010330 A5 JP 2016010330A5
Authority
JP
Japan
Prior art keywords
ips cells
foreign
cells
gene
episomal vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014132622A
Other languages
Japanese (ja)
Other versions
JP2016010330A (en
JP6469371B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2014132622A priority Critical patent/JP6469371B2/en
Priority claimed from JP2014132622A external-priority patent/JP6469371B2/en
Publication of JP2016010330A publication Critical patent/JP2016010330A/en
Publication of JP2016010330A5 publication Critical patent/JP2016010330A5/ja
Application granted granted Critical
Publication of JP6469371B2 publication Critical patent/JP6469371B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (11)

ヒト人工多能性幹細胞(iPS細胞)から成る胚様体に複数の外来遺伝子を発現させる方法であって、
1)エピソーマルベクターを用いて、iPS細胞に外来遺伝子を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてトランスフェクションする工程、
2)外来遺伝子がトランスフェクションされたiPS細胞を、薬剤選択マーカー及び/又はレポーター遺伝子を用いて選別する工程、及び
3)選別されたiPS細胞を、非静的な培養方法で培養し、胚様体まで増殖させる工程
を含む方法。
A method of expressing a plurality of foreign genes in an embryoid body composed of human induced pluripotent stem cells (iPS cells),
1) Transfecting an iPS cell with a foreign gene using a non-liposomal cationic lipid transfection reagent using an episomal vector,
2) a step of selecting iPS cells transfected with a foreign gene using a drug selection marker and / or a reporter gene, and 3) culturing the selected iPS cells by a non-static culture method, A method comprising the step of growing to the body.
前記外来遺伝子が2種以上であり、遺伝子毎に異なる薬剤選択マーカー及び/又はレポーター遺伝子を組み合わせてエピソーマルベクター構築物を作製することを特徴とする、請求項1に記載の方法。   2. The method according to claim 1, wherein two or more foreign genes are used, and an episomal vector construct is prepared by combining different drug selection markers and / or reporter genes for each gene. 前記外来遺伝子が2種であり、外来遺伝子毎に異なる薬剤選択マーカー及び/又は配列番号7又は8に記載の配列を有するレポーター遺伝子から選択される核酸を含むことを特徴とする、請求項1又は2に記載の方法。   The foreign gene comprises two kinds of foreign genes, and includes a nucleic acid selected from a drug selection marker different for each foreign gene and / or a reporter gene having the sequence of SEQ ID NO: 7 or 8. 2. The method according to 2. 前記外来遺伝子が、分化を誘導する転写因子より選ばれることを特徴とする、請求項1から3のいずれか1項に記載の方法。   The method according to any one of claims 1 to 3, wherein the foreign gene is selected from transcription factors that induce differentiation. 前記転写因子は、FOXA2、GATA4、HEX及びC/EBPαからなる群から選択される2種以上であることを特徴とする、請求項4に記載の方法。   The method according to claim 4, wherein the transcription factor is two or more selected from the group consisting of FOXA2, GATA4, HEX and C / EBPα. 前記非静的な培養方法は回転培養法であることを特徴とする、請求項1から5のいずれか1項に記載の方法。   The method according to any one of claims 1 to 5, wherein the non-static culture method is a rotary culture method. 前記回転培養法における培養時の回転速度が2.5から9.9rpmであることを特徴とする、請求項6に記載の方法。   The method according to claim 6, wherein a rotational speed at the time of culture in the rotary culture method is 2.5 to 9.9 rpm. 前記iPS細胞の培養は、1.6から160×10個/mLの細胞濃度のiPS細胞の懸濁液を添加して培養することを特徴とする、請求項1から7のいずれか1項に記載の方法。 The iPS cell culture is performed by adding a suspension of iPS cells having a cell concentration of 1.6 to 160 × 10 3 cells / mL, and culturing the iPS cells. The method described in 1. ヒト人工多能性幹細胞(iPS細胞)から成る外来遺伝子が導入された胚様体であって、
1)エピソーマルベクターを用いて、iPS細胞に外来遺伝子を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてトランスフェクションする工程、
2)外来遺伝子がトランスフェクションされたiPS細胞を、薬剤選択マーカー及び/又はレポーター遺伝子を用いて選別する工程、及び
3)選別されたiPS細胞を、非静的な培養方法で培養し、胚様体まで増殖させる工程
を含む方法で製造された胚様体。
An embryoid body into which a foreign gene consisting of human induced pluripotent stem cells (iPS cells) has been introduced,
1) Transfecting an iPS cell with a foreign gene using a non-liposomal cationic lipid transfection reagent using an episomal vector,
2) selecting iPS cells transfected with a foreign gene using a drug selection marker and / or a reporter gene; and
3) A step of culturing selected iPS cells by a non-static culture method and allowing them to grow to embryoid bodies
An embryoid body produced by a method comprising:
ヒト人工多能性幹細胞(iPS細胞)から成る胚様体に複数の外来遺伝子を発現させる方法であって、
1)エピソーマルベクターに、
(i) 外来遺伝子、
(ii) G418(登録商標)又はハイグロマイシンBに対する薬剤選択マーカー、及び、
(iii) EGFPをコードする核酸配列(配列番号7)又はCherryPicker(登録商標)をコードする核酸配列(配列番号8)を有するレポーター遺伝子の(i)ないし(iii)を組み合わせて組み込んだ複数の種類のエピソーマルベクター構築物を作製する工程、
2)複数のエピソーマルベクター構築物を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてiPS細胞にトランスフェクションすることにより、複数の外来遺伝子をiPS細胞にトランスフェクションする工程、
3) (i)ないし(iii)の組み合わせに対応して、
G418及び/又はハイグロマイシンBの添加により薬剤選択マーカーを用いて、及び/又は、
緑色及び/又は赤色の蛍光を指標としてレポーター遺伝子を用いて、
前記複数の外来遺伝子が導入されたiPS細胞を選別する工程、並びに、
4)選別されたiPS細胞を、1.6から160×10個/mLの細胞濃度で、回転速度2.5から9.9rpmの回転培養法で培養し、胚様体まで増殖させる工程
を含む方法。
A method of expressing a plurality of foreign genes in an embryoid body composed of human induced pluripotent stem cells (iPS cells),
1) In episomal vector,
(i) foreign genes,
(ii) a drug selection marker for G418® or hygromycin B, and
(iii) Multiple types of reporter genes (i) to (iii) incorporated in combination with a nucleic acid sequence encoding EGFP (SEQ ID NO: 7) or a nucleic acid sequence encoding Cherry Picker (registered trademark) (SEQ ID NO: 8) Producing an episomal vector construct of
2) transfecting a plurality of foreign genes into iPS cells by transfecting a plurality of episomal vector constructs into iPS cells using a non-liposomal cationic lipid transfection reagent;
3) Corresponding to the combination of (i) to (iii),
Using drug selection markers by the addition of G418 and / or hygromycin B, and / or
Using a reporter gene with green and / or red fluorescence as an indicator,
Selecting iPS cells into which the plurality of foreign genes have been introduced, and
4) A step of culturing the selected iPS cells at a cell concentration of 1.6 to 160 × 10 3 cells / mL by a rotary culture method at a rotational speed of 2.5 to 9.9 rpm, and proliferating to an embryoid body. Including methods.
ヒト人工多能性幹細胞(iPS細胞)から成る外来遺伝子が導入された胚様体であって、  An embryoid body into which a foreign gene consisting of human induced pluripotent stem cells (iPS cells) has been introduced,
1)エピソーマルベクターに、1) In episomal vector,
(i) 外来遺伝子、(i) foreign genes,
(ii) G418(登録商標)又はハイグロマイシンBに対する薬剤選択マーカー、及び、(ii) a drug selection marker for G418® or hygromycin B, and
(iii) EGFPをコードする核酸配列(配列番号7)又はCherryPicker(登録商標)をコードする核酸配列(配列番号8)を有するレポーター遺伝子の(i)ないし(iii)を組み合わせて組み込んだ複数の種類のエピソーマルベクター構築物を作製する工程、(iii) Multiple types of reporter genes (i) to (iii) incorporated in combination with a nucleic acid sequence encoding EGFP (SEQ ID NO: 7) or a nucleic acid sequence encoding Cherry Picker (registered trademark) (SEQ ID NO: 8) Producing an episomal vector construct of
2)複数のエピソーマルベクター構築物を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてiPS細胞にトランスフェクションすることにより、複数の外来遺伝子をiPS細胞にトランスフェクションする工程、2) transfecting a plurality of foreign genes into iPS cells by transfecting a plurality of episomal vector constructs into iPS cells using a non-liposomal cationic lipid transfection reagent;
3) (i)ないし(iii)の組み合わせに対応して、3) Corresponding to the combination of (i) to (iii),
G418及び/又はハイグロマイシンBの添加により薬剤選択マーカーを用いて、及び/又は、Using drug selection markers by the addition of G418 and / or hygromycin B, and / or
緑色及び/又は赤色の蛍光を指標としてレポーター遺伝子を用いて、Using a reporter gene with green and / or red fluorescence as an indicator,
前記複数の外来遺伝子が導入されたiPS細胞を選別する工程、並びに、Selecting iPS cells into which the plurality of foreign genes have been introduced, and
4)選別されたiPS細胞を、1.6から160×104) Select iPS cells from 1.6 to 160 × 10 6 3 個/mLの細胞濃度で、回転速度2.5から9.9rpmの回転培養法で培養し、胚様体まで増殖させる工程A step of cultivating the cells to the embryoid body by culturing by a rotational culture method at a cell rotation rate of 2.5 to 9.9 rpm at a cell concentration of 1 cell / mL
を含む方法で製造された胚様体。An embryoid body produced by a method comprising:
JP2014132622A 2014-06-27 2014-06-27 A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells) Active JP6469371B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014132622A JP6469371B2 (en) 2014-06-27 2014-06-27 A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014132622A JP6469371B2 (en) 2014-06-27 2014-06-27 A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells)

Publications (3)

Publication Number Publication Date
JP2016010330A JP2016010330A (en) 2016-01-21
JP2016010330A5 true JP2016010330A5 (en) 2017-08-10
JP6469371B2 JP6469371B2 (en) 2019-02-13

Family

ID=55227519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014132622A Active JP6469371B2 (en) 2014-06-27 2014-06-27 A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells)

Country Status (1)

Country Link
JP (1) JP6469371B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190141218A (en) * 2017-04-26 2019-12-23 메모리얼 슬로안 케터링 캔서 센터 Cryopreservation Cells Ready for Use
CN107164527B (en) * 2017-06-29 2018-04-20 杭州观梓健康科技有限公司 It is a kind of to screen the method for participating in multipotential stem cell vitro directed differentiation regulatory factor
CN111139218A (en) * 2020-01-16 2020-05-12 协和干细胞基因工程有限公司 Method for rapidly and efficiently preparing embryoid body by inducing pluripotent stem cell or embryonic stem cell

Similar Documents

Publication Publication Date Title
CN104178461B (en) CAS9-carrying recombinant adenovirus and application thereof
JP7154525B2 (en) Cell microcompartments and methods for their preparation
CN107922944A (en) Engineered CRISPR CAS9 compositions and application method
JP2019520844A5 (en)
Tanaka et al. Ultrastructure and membrane traffic during cell division in the marine pennate diatom Phaeodactylum tricornutum
JP2014533491A5 (en)
JP2018526992A5 (en)
CN109689865A (en) BCL11A homing endonuclease variants, composition and application method
CN110300803A (en) Improve the method in cellular genome with source orientation reparation (HDR) efficiency
LeBlanc et al. RNA trafficking in parasitic plant systems
EP4249036A3 (en) Methods and products for nucleic acid production and delivery
Cherbas et al. Cell lines
Sabatino et al. Establishment of genetic transformation in the sexually reproducing diatoms Pseudo-nitzschia multistriata and Pseudo-nitzschia arenysensis and inheritance of the transgene
CN102703424B (en) A kind of method of genome of E.coli point mutation of recombined engineering mediation
NZ616646A (en) Synthetic genes
CN108342362A (en) A kind of stable cell lines MDCK and its construction method for expanding recombination hepatitis infectiosa canis virus CAV2
JP2016010330A5 (en)
US20170369878A1 (en) Microrna combinations for anti-cancer therapeutics
JP2016027797A5 (en)
JP2012143229A5 (en)
JP2014516530A5 (en)
CN104726500A (en) Application of MicroRNA26b-3p inhibitor in preparation of human umbilical cord derived mesenchymal stem cell
KR101776368B1 (en) mRNA nanoparticles and manufacturing method thereof
CN102628029B (en) Thalassemia-induced multipotent stem cell as well as preparation method and application thereof
CN108239620B (en) MDCK cell strain with IFN-beta 1 coding gene deletion and construction method and application thereof